27 May 2013
Keywords: fda, oks, expanded, label, cubist, cubicin, food
Article | 05 June 2006
The US Food and Drug Administration has approved Cubist Pharmaceuticals' supplemental new drug application for Cubicin (daptomycin for injection)
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 June 2006
12 June 2006
24 May 2013
© 2013 thepharmaletter.com